Mga Batayang Estadistika
| CIK | 1865975 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AfterNext HealthTech Acquisition Corp. Units, each consisting of one Class A ordinary share and one-
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 11, 2023 |
SC 13G/A 1 guggenheim-aftr083123a3.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G01109118** (CUSIP Number) August 31, 2023 (Date of Event Which Requires Fil |
|
| August 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40737 AFTERNEXT HEALTHTECH ACQUISITION CORP. (Exact name of registrant a |
|
| August 16, 2023 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on August 28, 2023, pursuant to the provisions of Rule 12d2-2 (a). |
|
| August 2, 2023 |
EX-99.1 Exhibit 99.1 August 2, 2023 Dear Shareholders, After thorough deliberations and in-depth analyses, we are disappointed to inform you that we have concluded that the best course of action to honor the trust and confidence you have placed in us is to proceed with the liquidation of AfterNext HealthTech Acquisition Corp. (“AFTR”) and to return capital to you. We formed AFTR to address the imm |
|
| August 2, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 2, 2023 Date of Report (Date of earliest event reported) AfterNext HealthTech Acquisition Corp. (Exact Name of Registrant as Specified in its Charter) Cayman Islands 001-40737 98-1595329 (State or other jurisdiction of incorpo |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30 , 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| February 15, 2023 |
AFTR / AfterNext HealthTech Acquisition Corp - Class A / GUGGENHEIM CAPITAL LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G01109188** (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appr |
|
| February 14, 2023 |
SC 13G/A 1 tm233474-22sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.000 |
|
| February 13, 2023 |
SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G01109100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check |
|
| February 13, 2023 |
AFTR / AfterNext HealthTech Acquisition Corp - Class A / ARISTEIA CAPITAL LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 5 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 5 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40737 AfterNext Hea |
|
| January 31, 2023 |
SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) AFTERNEXT HEALTHTECH ACQUISITION CORP. (Name of Issuer) CLASS A ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G01109100 (CUSIP Number) DECEMBER 31, 2022 (Date of event which requires filing of this statement) Che |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| September 12, 2022 |
AFTR / AfterNext HealthTech Acquisition Corp - Class A / GUGGENHEIM CAPITAL LLC Passive Investment SC 13G/A 1 guggenheim-aftr083122a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G01109188** (CUSIP Number) August 31, 2022 (Date of Event Which Requires Fil |
|
| August 11, 2022 |
EXHIBIT 99.1 JOINT FILING AGREEMENT Each of the undersigned hereby acknowledges and agrees, in compliance with the provisions of Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, that the Schedule 13G to which this Agreement is attached as an Exhibit, and any amendments thereto, will be filed with the Securities and Exchange Commission jointly on behalf of the und |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 AfterNext HealthTech Acquisition Corp (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Titles of Class of Securities) G01109100 (CUSIP Number) August 5, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropria |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. 1)* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (the ?Shares?) (Title of Class |
|
| February 14, 2022 |
AFTR / AfterNext HealthTech Acquisition Corp - Class A / UBS OCONNOR LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) G01109100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appro |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, par value $0.0001 (Titles of Class of Securities) G01109100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40737 AfterNext Healt |
|
| November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| September 29, 2021 |
Exhibit 99.1 AfterNext HealthTech Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing October 4, 2021 SAN FRANCISCO AND FORT WORTH, TX ? September 29, 2021 ? AfterNext HealthTech Acquisition Corp. (?AfterNext? or ?the Company?) announced that, commencing October 4, 2021, holders of the units sold in the Company?s initial public offering of 25,000 |
|
| September 29, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2021 AfterNext HealthTech Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40737 98-1595329 (State or other jurisdicti |
|
| September 22, 2021 |
Administrative Services Agreement, dated August 11, 2021 between the Company and TPG Global, LLC. EX-10.3 2 aftru-ex10333.htm EX-10.3 Exhibit 10.3 EXECUTION VERSION AfterNext HealthTech Acquisition Corp. 301 Commerce St. Suite 3300 Fort Worth, TX 76102 August 11, 2021 TPG Global, LLC 301 Commerce St. Suite 3300 Fort Worth, TX 76102 Re: Administrative Services Agreement Gentlemen: This letter will confirm our agreement that, commencing on the date the shares of AfterNext HealthTech Acquisition |
|
| September 22, 2021 |
Engagement Letter between the Registrant and TPG Capital BD, LLC Exhibit 10.6 EXECUTION VERSION CONFIDENTIAL August 11, 2021 AfterNext HealthTech Acquisition Corp. 301 Commerce St., Suite 3300 Fort Worth, TX 76102 Attention: Art Heidrich, Secretary Re: Engagement of Services Dear Art Heidrich: This will confirm the basis upon which AfterNext HealthTech Acquisition Corp. (?Client?) has engaged TPG Capital BD, LLC (?TPG Capital BD?) to provide independent financi |
|
| September 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40737 AfterNext HealthTech Acquisition Corp. |
|
| September 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G01109188** (CUSIP Number) August 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropria |
|
| August 26, 2021 |
CITADEL ADVISORS LLC - AFTERNEXT HEALTHTECH ACQUISITION CORP. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2 (Amendment No. )* AfterNext HealthTech Acquisition Corp. (Name of Issuer) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securities) |
|
| August 26, 2021 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the Class A ordinary shares of AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, a |
|
| August 20, 2021 |
Financial Statements and Exhibits, Other Events 8-K 1 d199799d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 16, 2021 AfterNext HealthTech Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40737 98-159329 (State or oth |
|
| August 20, 2021 |
Exhibit 99.1 AFTERNEXT HEALTHTECH ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Financial Statement: Balance Sheet F-3 Notes to Balance Sheet F-4 F-1 Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Directors AfterNext HealthTech Acquisition Corp.: Opinion on the Financial Statement We have audited the accompanying balance she |
|
| August 19, 2021 |
INTEGRATED CORE STRATEGIES (US) LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 AFTERNEXT HEALTHTECH ACQUISITION CORP. (Name of Issuer) CLASS A ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) G01109118** (CUSIP Number) AUGUST 12, 2021 (Date of event which requires filing of this statement) Check the appropriate box to desig |
|
| August 16, 2021 |
EX-3.1 3 d215796dex31.htm EX-3.1 Exhibit 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman AfterNext HealthTech Acquisition Corp. (ROC # 374209) (the “Company”) TAKE NOTICE that by written resolution of the sole shareholder of the Company dated 11 August 2021, the following special resolution was passed: 1 Adoption of Amended and Restated Memor |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 AfterNext HealthTech Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 001-40737 98-159329 (State or other jurisdiction o |
|
| August 16, 2021 |
EX-10.2 6 d215796dex102.htm EX-10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of August 12, 2021, by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Com |
|
| August 16, 2021 |
AfterNext HealthTech Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering Exhibit 99.1 August 10, 2021 AfterNext HealthTech Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering FORT WORTH, TX ? AUGUST 11, 2021 ? AfterNext HealthTech Acquisition Corp. (?AfterNext? or the ?Company?), a special purpose acquisition company incorporated as a Cayman Islands exempted company focused on the intersection of healthcare and technology, today announced the pr |
|
| August 16, 2021 |
Exhibit 1.1 25,000,000 Units AfterNext HealthTech Acquisition Corp. UNDERWRITING AGREEMENT August 11, 2021 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Deutsche Bank Securities Inc. 60 Wall Street New York, New York 10005 BofA Securities, Inc. One Bryant Park New York, New York 10036 As Representatives of the several Underwriters Ladies and Gentlemen: AfterNext HealthTech Acqui |
|
| August 16, 2021 |
AfterNext HealthTech Acquisition Corp. Announces Closing of $250 Million Initial Public Offering Exhibit 99.2 AfterNext HealthTech Acquisition Corp. Announces Closing of $250 Million Initial Public Offering SAN FRANCISCO AND FORT WORTH, TX ? AUGUST 16, 2021 ? AfterNext HealthTech Acquisition Corp. (?AfterNext? or ?the Company?), a special purpose acquisition company focused on the intersection of healthcare and technology, today announced the closing of its previously announced initial public |
|
| August 16, 2021 |
Exhibit 10.1 August 11, 2021 AfterNext HealthTech Acquisition Corp. 301 Commerce St., Suite 3300 Fort Worth, TX 76102 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into or proposed to be entered into by and among AfterNext HealthTech Acquisition C |
|
| August 16, 2021 |
Exhibit 4.1 AFTERNEXT HEALTHTECH ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY WARRANT AGREEMENT Dated as of August 12, 2021 THIS WARRANT AGREEMENT (this ?Agreement?), dated as of August 12, 2021, is by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as |
|
| August 16, 2021 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of August 11, 2021, is made and entered into by and among AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and AfterNext HealthTech Sponsor, Series LLC, a Delaware series limited liability company (the ?Sponsor?) and the undersigned parties listed und |
|
| August 16, 2021 |
EX-10.4 8 d215796dex104.htm EX-10.4 Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, effective as of August 11, 2021 (as it may from time to time be amended, this “Agreement”), is entered into by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the “Company”), and AfterNext HealthTech Sponsor, Serie |
|
| August 13, 2021 |
$250,000,000 AfterNext HealthTech Acquisition Corp. 25,000,000 Units Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-257815 PROSPECTUS $250,000,000 AfterNext HealthTech Acquisition Corp. 25,000,000 Units AfterNext HealthTech Acquisition Corp. is a newly organized blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or sim |
|
| August 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 AfterNext HealthTech Acquisition Corp. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1595329 (State or other jurisdiction of incorporation or organization) (I.R.S. Employ |
|
| August 9, 2021 |
AFTERNEXT HEALTHTECH ACQUISITION CORP. 301 Commerce St. Suite 3300 Fort Worth, TX 76102 AFTERNEXT HEALTHTECH ACQUISITION CORP. 301 Commerce St. Suite 3300 Fort Worth, TX 76102 August 9, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-4628 Attn: Irene Barberena-Meissner Re: AfterNext HealthTech Acquisition Corp. Registration Statement on Form S-1 File No. 333-257815 Dear Ms. Barberena-Meissner: AfterNext Healt |
|
| August 9, 2021 |
Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Deutsche Bank Securities Inc. 60 Wall Street New York, New York 10005 BofA Securities, Inc. One Bryant Park New York, New York 10036 August 9, 2021 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance Office of Energy and Transportation 100 F Street, N.E. Washington, D.C. 20549 Attention: Gus Rodriguez Sondra Sn |
|
| August 6, 2021 |
As filed with the U.S. Securities and Exchange Commission on August 5, 2021. S-1/A 1 d177739ds1a.htm S-1/A As filed with the U.S. Securities and Exchange Commission on August 5, 2021. Registration No. 333-257815 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AfterNext HealthTech Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands |
|
| August 6, 2021 |
Exhibit 10.6 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, effective as of [?], 2021 (as it may from time to time be amended, this ?Agreement?), is entered into by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and AfterNext HealthTech Sponsor, Series LLC, a Delaware series limited liability |
|
| August 6, 2021 |
Form of Underwriting Agreement. Exhibit 1.1 25,000,000 Units AfterNext HealthTech Acquisition Corp. UNDERWRITING AGREEMENT August [?], 2021 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Deutsche Bank Securities Inc. 60 Wall Street New York, New York 10005 BofA Securities, Inc. One Bryant Park New York, New York 10036 As Representatives of the several Underwriters Ladies and Gentlemen: AfterNext HealthTech Acqu |
|
| July 30, 2021 |
Exhibit 10.3 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [?], 2021, by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, |
|
| July 30, 2021 |
Exhibit 10.2 [?], 2021 AfterNext HealthTech Acquisition Corp. 301 Commerce St., Suite 3300 Fort Worth, TX 76102 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into or proposed to be entered into by and among AfterNext HealthTech Acquisition Corp., |
|
| July 30, 2021 |
Exhibit 10.6 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, effective as of [?], 2021 (as it may from time to time be amended, this ?Agreement?), is entered into by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and AfterNext HealthTech Sponsor, Series LLC, a Delaware series limited liability |
|
| July 30, 2021 |
Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant. Exhibit 4.4 AFTERNEXT HEALTHTECH ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY WARRANT AGREEMENT Dated as of [?], 2021 THIS WARRANT AGREEMENT (this ?Agreement?), dated as of [?], 2021, is by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agen |
|
| July 30, 2021 |
Form of Amended and Restated Memorandum and Articles of Association. Exhibit 3.3 THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF AFTERNEXT HEALTHTECH ACQUISITION CORP. (ADOPTED BY SPECIAL RESOLUTION DATED [DATE] AND EFFECTIVE ON [DATE]) THE COMPANIES ACT (AS REVISED) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF AFTERNEXT |
|
| July 30, 2021 |
Form of Promissory Note issued to AfterNext HealthTech Sponsor, Series LLC. Exhibit 10.1 THIS PROMISSORY NOTE (?NOTE?) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| July 30, 2021 |
Exhibit 4.1 SPECIMEN UNIT CERTIFICATE NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS AfterNext HealthTech Acquisition Corp. CUSIP [ ? ] UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-THIRD OF ONE REDEEMABLE WARRANT TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of Units. Each Unit (?Unit?) consists of one (1) Class A ordinary share, par value $0.0001 per share |
|
| July 30, 2021 |
Form of Registration Rights Agreement among the Registrant and certain security holders. Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of [?], 2021, is made and entered into by and among AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the ?Company?), and AfterNext HealthTech Sponsor, Series LLC, a Delaware series limited liability company (the ?Sponsor?) and the undersigned parties listed under Hol |
|
| July 30, 2021 |
Exhibit 4.3 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW AFTERNEXT HEALTHTECH ACQUISITION CORP. Incorporated Under the Laws of the Cayman Islands CUSIP [?] Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the r |
|
| July 30, 2021 |
As filed with the U.S. Securities and Exchange Commission on July 29, 2021. Table of Contents As filed with the U.S. Securities and Exchange Commission on July 29, 2021. Registration No. 333-257815 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AfterNext HealthTech Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-15953 |
|
| July 29, 2021 |
1271 Avenue of the Americas New York, New York 10020-1401 Tel: +1.212.906.1200 Fax: +1.212.751.4864 www.lw.com July 29, 2021 FIRM / AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo |
|
| July 9, 2021 |
EX-99.4 16 d177739dex994.htm EX-99.4 Exhibit 99.4 Consent The undersigned hereby consents to being names in the registration statement on Form S-1, in each related prospectus and in all subsequent amendments and post-effective amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Ac |
|
| July 9, 2021 |
Exhibit 10.2 [?], 2021 AfterNext HealthTech Acquisition Corp. 301 Commerce St., Suite 3300 Fort Worth, TX 76102 Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) entered into or proposed to be entered into by and among AfterNext HealthTech Acquisition Corp., |
|
| July 9, 2021 |
Consent of Dr. Julie Gerberding Exhibit 99.2 Consent The undersigned hereby consents to being names in the registration statement on Form S-1, in each related prospectus and in all subsequent amendments and post-effective amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act (the ?Registration Statement?) and |
|
| July 9, 2021 |
Exhibit 99.1 Consent The undersigned hereby consents to being names in the registration statement on Form S-1, in each related prospectus and in all subsequent amendments and post-effective amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act (the ?Registration Statement?) and |
|
| July 9, 2021 |
Exhibit 99.5 Consent The undersigned hereby consents to being names in the registration statement on Form S-1, in each related prospectus and in all subsequent amendments and post-effective amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act (the “Registration Statement”) and |
|
| July 9, 2021 |
EX-4.2 5 d177739dex42.htm EX-4.2 Exhibit 4.2 SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE NUMBER SHARES AFTERNEXT HEALTHTECH ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [ ●] This certifies that is the owner of . FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF US$0.0001 EACH OF AFTERNE |
|
| July 9, 2021 |
Consent of Christopher H. Hunter Exhibit 99.3 Consent The undersigned hereby consents to being names in the registration statement on Form S-1, in each related prospectus and in all subsequent amendments and post-effective amendments or supplements thereto and in any registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act (the “Registration Statement”) and |
|
| July 9, 2021 |
1271 Avenue of the Americas New York, New York 10020-1401 Tel: +1.212.906.1200 Fax: +1.212.751.4864 www.lw.com July 9, 2021 FIRM / AFFILIATE OFFICES Beijing Boston Brussels Century City Chicago Dubai D?sseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo W |
|
| July 9, 2021 |
Exhibit 4.1 SPECIMEN UNIT CERTIFICATE NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS AfterNext HealthTech Acquisition Corp. CUSIP [ ? ] UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-FOURTH OF ONE REDEEMABLE WARRANT TO PURCHASE ONE CLASS A ORDINARY SHARE THIS CERTIFIES THAT is the owner of Units. Each Unit (?Unit?) consists of one (1) Class A ordinary share, par value $0.0001 per shar |
|
| July 9, 2021 |
Exhibit 3.1 MC-374209 Certificate Of Incorporation I, MELANIE E. RIVERS Assistant Registrar of Companies of the Cayman Islands DO HEREBY CERTIFY, pursuant to the Companies Act CAP. 22, that all requirements of the said Act in respect of registration were complied with by AfterNext HealthTech Acquisition Corp. an Exempted Company incorporated in the Cayman Islands with Limited Liability with effect |
|
| July 9, 2021 |
EX-10.6 8 d177739dex106.htm EX-10.6 Exhibit 10.6 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, effective as of [•], 2021 (as it may from time to time be amended, this “Agreement”), is entered into by and between AfterNext HealthTech Acquisition Corp., a Cayman Islands exempted company (the “Company”), and AfterNext HealthTech Sponsor, Series LLC, |
|
| July 9, 2021 |
EX-10.7 9 d177739dex107.htm EX-10.7 Exhibit 10.7 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [•], 2021. Between: (1) AFTERNEXT HEALTHTECH ACQUISITION CORP., an exempted company incorporated under the laws of the Cayman Islands with registered office at P.O. Box 309, Ugland House, KYI-1104, Grand Cayman, Cayman Islands (the “Company”); and (2) [•] (“Indemnitee”). W |
|
| July 9, 2021 |
Amended and Restated Memorandum and Articles of Association EX-3.2 3 d177739dex32.htm EX-3.2 Exhibit 3.2 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman AfterNext HealthTech Acquisition Corp. (ROC #374209) (the “Company”) TAKE NOTICE that by written resolution of the sole shareholder of the Company dated 23 April 2021, the following special resolution was passed: 1. the authorised and existing share capit |
|
| July 9, 2021 |
Exhibit 10.8 AfterNext HealthTech Acquisition Corp. 301 Commerce St. Suite 3300 Fort Worth, TX 76102 [ ? ], 2021 TPG Global, LLC 301 Commerce St. Suite 3300 Fort Worth, TX 76102 Re: Administrative Services Agreement Gentlemen: This letter will confirm our agreement that, commencing on the date the shares of AfterNext HealthTech Acquisition Corp. (the ?Company?) are first listed on the New York Sto |
|
| July 9, 2021 |
EX-10.5 7 d177739dex105.htm EX-10.5 Exhibit 10.5 AfterNext HealthTech Acquisition Corp. c/o TPG Global, LLC 301 Commerce St., Suite 3300 Fort Worth, TX 76102 AfterNext HealthTech Sponsor (Series S-1) May 4, 2021 301 Commerce St., Suite 3300 Fort Worth, TX 76102 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement and the terms hereof (this “Agreement”) memorializes the purcha |
|
| July 9, 2021 |
Power of Attorney (included on signature page of this Registration Statement).* Table of Contents As filed with the U.S. Securities and Exchange Commission on July 9, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AfterNext HealthTech Acquisition Corp. (Exact name of registrant as specified in its charter) Cayman Islands 6770 98-1595329 (State or Other Jurisdi |
|
| July 9, 2021 |
EX-10.9 11 d177739dex109.htm EX-10.9 Exhibit 10.9 [●], 2021 AfterNext HealthTech Acquisition Corp. 301 Commerce St., Suite 3300 Fort Worth, TX 76102 Attention: Secretary Re: Engagement of Services Dear Secretary: This will confirm the basis upon which AfterNext HealthTech Acquisition Corp. (“Client”) has engaged TPG Capital BD, LLC (“TPG Capital BD”) to provide independent financial consulting ser |
|
| June 7, 2021 |
Table of Contents This is a confidential draft submission to the U.S. Securities and Exchange Commission on June 7, 2021 and is not being filed under the Securities Act of 1933, as amended. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AfterNext HealthTech Acquisition Corp. (Exact name |
